Eton Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held on June 22, 2021, in Deer Park, Illinois. Eton Pharmaceuticals, Inc. is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1: Election of Directors
- Sean E. Brynjelsen: Elected with 13,174,455 votes For, 983,738 Against, and 37,398 Abstentions. There were 4,774,148 Broker Non-Votes.
- Norbert G. Riedel: Elected with 11,995,591 votes For, 2,162,602 Against, and 37,398 Abstentions. There were 4,774,148 Broker Non-Votes.
- Proposal 2: Ratification of Auditors
- KMJ Corbin & Company LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2021.
- Votes: 17,416,440 For, 1,414,537 Against, and 138,762 Abstentions. There were 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Sean E. Brynjelsen and Norbert G. Riedel were elected to the Board of Directors for three-year terms.
- KMJ Corbin & Company LLP was confirmed as the independent auditor for fiscal year 2021.
- A significant number of Broker Non-Votes (4,774,148) were recorded for the director elections, indicating shares held by brokers that were not voted on these matters.
- The company has elected to use the extended transition period for complying with new or revised financial accounting standards as an emerging growth company.